A
Agpharma
This theranostics company develops monoclonal antibodies that target cancer-specific biomarkers for therapeutic and diagnostic applications. Their products aim to selectively target the causes of tumor growth, enabling personalized cancer care.
Traction –/10
HQ unknown
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- This theranostics company develops monoclonal antibodies that target cancer-specific biomarkers for therapeutic and diagnostic applications. Their products aim to selectively target the causes of tumor growth, enabling personalized cancer care.